Back

Impact of impaired glucose metabolism on coronary atherosclerosis in patients with very low LDL cholesterol: a potential framework to understand residual risk in chronic coronary syndromes.

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Old and new biomarkers and their impact on cardiovascular prognosis Noninvasive Diagnostic Methods ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Danilo Neglia

Toscana Gabriele Monasterio Foundation, Pisa (Italy)

7 More presentations in this session

Presentation thumbnail
Residual atherosclerotic risk in older patients with ASCVD: where hsCRP meets Lp(a)
Doctor H. Wang (Beijing, CN)
Abstract Slides
Presentation thumbnail
Deciphering diagnostic markers and immune infiltration in ischemic cardiomyopathy: insights from cuproptosis-related genes via bioinformatics and experimental approaches
Doctor X. Tan (Suzhou, CN)
Abstract Slides Video
Presentation thumbnail
Metabolomic profiling of coronary and radial artery samples identifies biomarkers and diagnostic models for coronary microvascular dysfunction
Doctor Q. Su (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Circulating microRNA signatures are associated with epicardial coronary dysfunction in patients underwent invasive physiological evaluation: The ANFIBIO Study
Doctor L. Matute Blanco (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
High-sensitivity C-Reactive protein predicts post-percutaneous coronary intervention cardiovascular risk with CKD status effect: evidence from a prospective registry study
Doctor H. Wang (Beijing, CN) Doctor X. Chen (Beijing, CN)
Abstract Slides

Access the full session

Session thumbnail
Old and new biomarkers and their impact on cardiovascular prognosis

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Does prediabetes diagnosed by hemoglobinA1c or oral glucose tolerance test predict coronary artery disease in patients suspected of chronic coronary syndrome?
thumbnail
Congress Presentation
Diabetes and prediabetes prevalence and guideline directed antidiabetic therapy in acute coronary syndrome and complex coronary interventions
thumbnail
Congress Presentation
Relationship between the new SCORE2-Diabetes and coronary atherosclerotic burden - a coronary calcium score correlation study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources